Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar
Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar
NEW YORK/BOSTON (Reuters) - Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle thousands of U.
Drugstore drones: UPS will fly CVS prescriptions to U.S. customers
Drugstore drones: UPS will fly CVS prescriptions to U.S. customers
LOS ANGELES (Reuters) - United Parcel Service Inc’s (UPS.
Researchers grow muscle cells on edible fibers
Researchers grow muscle cells on edible fibers
You can see the long, thin fibers of skeleton muscle in this close-up of prosciutto ham.
FDA approves new drug for most common form of cystic fibrosis
FDA approves new drug for most common form of cystic fibrosis
Trikafta (elexacaftor/ivacaftor/tezacaftor) is the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation.
Researchers identify a new way to target treatment-resistant cancers
Researchers identify a new way to target treatment-resistant cancers
An international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.
Biogen surges 42% after stunning reversal sees it revive plans for Alzheimer's treatment
Biogen surges 42% after stunning reversal sees it revive plans for Alzheimer's treatment
Shares of Biogen surged more than 42% on Tuesday morning after the company announced plans to seek approval for an experimental Alzheimer's treatment called aducanumab.
A new theory on depression: It’s a disease caused by the body’s immune system
A new theory on depression: It’s a disease caused by the body’s immune system
The idea that depression might be caused by a chemical imbalance in the brain – and not a moral failing – grew in popularity with the invention of the drug Prozac in the late ‘80s, and later wit...
Trump urges quicker action to allow imported drugs from Canada
Trump urges quicker action to allow imported drugs from Canada
WASHINGTON (Reuters) - U.
Alexion acquiring Achillion to expand reach into rare, immune-related disease
Alexion acquiring Achillion to expand reach into rare, immune-related disease
Alexion Pharmaceuticals (ALXN) said Wednesday that it will acquire Achillion Pharmaceuticals (ACHN) to expand its pipeline of experimental drugs targeting rare diseases of the immune s...
FDA generic drug approvals reach record high in fiscal year 2019
FDA generic drug approvals reach record high in fiscal year 2019
Statement From.
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
SAN DIEGO, Sept.
Israel's Healthy.io raises $60 million, gets FDA ok for urine test
Israel's Healthy.io raises $60 million, gets FDA ok for urine test
TEL AVIV (Reuters) - Israel’s Healthy.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand